| Mrs Jannie Hartsfield, | |
|
418 West7th St, Columbia, TN 38401 | |
| (931) 388-0078 | |
| (931) 388-0866 |
| Full Name | Mrs Jannie Hartsfield |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 418 West7th St, Columbia, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063540771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jannie Hartsfield, 109 River Heights Dr, Columbia, TN 38401-2323 Ph: (931) 381-5164 | Mrs Jannie Hartsfield, 418 West7th St, Columbia, TN 38401 Ph: (931) 388-0078 |
News Archive
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
Personalized cancer treatment is one step closer to becoming a reality for more patients, thanks to a Cancer Council Beat Cancer Project grant awarded to the University of South Australia researcher Dr. Stephanie Reuter Lange to explore how computer-based modeling can optimize cancer treatment and remove the need for expensive clinical trials.
The comprehensive report calls for major changes in doctor training and points out that it is difficult to track how the $15 billion spent by the federal government is being used.
What sounds like a dream of the future has already been the subject of research for a few years: simply printing out tissue and organs. Now scientists have further refined the technology and are able to produce various tissue types.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
› Verified 8 days ago
Rebecca Diane Hill, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1222 Medical Center Dr, Columbia, TN 38401 Phone: 931-490-1585 Fax: 931-490-1505 | |
Ms. Michele Yvonne Davis, B.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 115 Dyer St, Suite 1, Columbia, TN 38401 Phone: 931-560-4220 Fax: 931-560-4221 | |
Ms. Charlene Brooks, B.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1222 Medical Center Dr, Columbia, TN 38401 Phone: 931-490-1500 Fax: 931-490-1505 | |
Donna English, BS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1222 Medical Center Dr, Columbia, TN 38401 Phone: 931-490-1500 | |
Mrs. Nioka Fawn Montgomery, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6011 Trotwood Ave # A, Columbia, TN 38401 Phone: 931-560-3061 Fax: 931-560-3062 | |
Mark Zachary Williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 115 Dyer St, Suite 1, Columbia, TN 38401 Phone: 931-560-4220 Fax: 931-560-4221 | |
Kristy Kay Jakes, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1222 Medical Center Dr, Columbia, TN 38401 Phone: 931-490-1585 Fax: 931-490-1505 |